Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent strategy that most here could get a good nights sleep over.
It is one whereby emotions are held at bay and logic is in control.
Most here are probably in at around 50 cents (my in is at .4880 and can't drop any appreciably lower, even with AXIM under 20 cents).
With projections of profitability just on the DED line alone by the end of 2022, AXIM will most certainly be trading North of $2 by the end of this year/beginning of next.
Keep in mind that the DED line of products are fully patented, fully approved, and are or will be soon marketed to the entire WORLD.
Inflation is hitting everyone, and even Doctors worldwide are going to be looking for a much less expensive way to diagnose their patients in order to reduce their bottom line.
AXIM's DED Line offers just that - a rapid and much less expensive way for eye doctors around the globe to better diagnose their patient's ailment, thus enabling them to better deal with rising prices overall, and perhaps even pass some of those savings onto their "customers".
We all would like to reach for the stars and make an unprecedented killing with Immunopass, but the worst case scenario (relying on the DED line) still could feasibly give most of us here a return of around 400% gain (imagine the gain for those just getting into AXIM now, at .20 or below?!).
Steady as she goes, and have patience.
So I have pretty much sold off all of the shares (NVAC) and most of the warrants (NVACW) in exchange for the Rights (NVACR).
I'm using my logic, that owning future rights to a share, at 1/5th of the cost of a current share, is the best bang for the buck, especially if one's intention has always been to hold and to only sell AFTER the announcement of the target.
After all, today's shares and today's future shares will be exactly equivalent at that time (except, of course, for how much they originally cost).
Seems to me that such a move would be the equivalent to almost a 500% gain, provided the stock value doesn't decrease upon the announcement of a target (which it truly shouldn't).
Truth is that I now only have the equivalent of 2.4 times the amount of "future" stock that I had of "present" stock, as I have not yet used up all of the dry powder (ie: I am about 75% along the way, and now want to see if I can pick up some cheapies over the next 2 1/2 weeks) AND I am spending a little of that extra dry powder whenever AXIM drops below 19 cents.
Still, 2.4 times is like a 240% increase, or if being pessimistic, the stock price after acquisition could drop to a little over $4 and I still won't have realized a loss (and by selling the warrants, I further reduce the downside of the stock trading under $11.50 - the target price of the warrants).
LOL, this is kind of like riding "Dueling Dragons" at Disney, only like being on both rollercoaster rides at the same time!
I am not sure if this would be considered a PUMP or a DUMP. but AXIM over 20 cents a share is too rich for my blood right now.
Imagine what it must be like to eat a gallon of your favorite ice cream, and after having done so, someone offers you more of the same at practically no cost!
Yeah....THAT. That is what AXIM over 20 cents a share is like for me right now.
Is that pumping or dumping?
LOL, and this will be my last attempt at logic.
Why would I pump AXIM?, and if I were, why would I be doing such a terrible job of it?
I only state my thoughts to put them out here, so that others can logically shoot them down and expose to me the error in my thinking.
Most of the time, I back up everything I say with links or technical facts that anyone can Google to see if they are accurate.
Even my earlier post....790 shares @.1871 this morning....I am assuming that must be the 1st and 5th trade of the day (albeit the 1st trade is only 140 shares @ .187, but I am guessing that the brokerage wasn't going to quibble about reporting a difference of 100th of a penny - which amounts to 1.4 cents).
LOL, and if I were pumping, would I further state that I am placing bids at the very bottom of the market? Wouldn't it be more logical to bash the stock and get others to drop their shares for my own personal gain?
Give me credit! All these weeks of pumping and the stock is now trading at its 52 week low?
Time to sit down in a quiet place and put on that thinking cap, and always remember to engage brain before engaging mouth (or fingers, however it is that you post).
As for AXIM, the only possible "pump" that can ever successfully occur is the one that the FDA can provide, if and when they decide to do so.
Till then, everything here should just be considered a discussion.
Oh, and by the way, what am I personally doing during this time (besides picking up shares of NVACR and keeping an eye on TWST, DWAC, and LCID)?
I have a bunch of small OPEN BIDS, just sitting out there, waiting for someone to abandon ship.
Yesterday I think I picked up about 479 shares at .187
Today, so far, I know I grabbed 790 shares at just about the same (.1871 - I don't know if more came in this afternoon, as I haven't checked in the last couple of hours, but it looks like most of the trading has moved to .20 or above, so I don't believe so).
I truly hope that each and everyone of you scores BIG with this one, since a rising tide raises ALL boats.
Godspeed.
You know, NO ONE commented on Dean14's post #2831 from the other day.
Did NO ONE else see its relevance?
Biden's "Cancer Moonshot" from 2016 is being re-visited!
Of course, as is each of our Right to do so (Private Messaging), but some of us (like myself) are too cheap to go for that "premium" service.
As I have shown you, though, there is a work-around to that, and of course, if you want to wait till Friday at, I believe, 4PM to 5PM EST, private messaging is free to all as a "teaser" to the premium service.
But keeping in mind that we are all here, collectively, to brainstorm this particular investment (AXIM), and PMs don't go towards helping the collective good.
I and another here practically PM but on an open board (NorthView Acquisition Corp. - NVAC) here on the Hub, but you could freely wander over there to see what is being said.
NorthView Acquisition Corp. is a Special Purpose Acquisition Corporation (SPAC) that launched its IPO on 12/23/2021 and has been moving at lightning speed ever since (On January 19, less than 1 month after it was formed, it split its UNITS into three separate trading pieces: Shares (NVAC), Rights (NVACR), and Warrants (NVACW).
I mention NVAC here because, at the discovery of one of our AXIM posters about 3 weeks ago, I followed an AXIM Board Member (Peter O'Rouke) over to NorthView.
Peter is one of 3 of the founding members of NorthView, and I think this one too is going to be quite an interesting prospect.
BUT, I caution every one here, SPACS may look pretty risky and are NOT for the average investor.
I myself have been chomping at the bit to get into Trump's SPAC (DWAC), which I am guessing is going to go through the roof once Truth Social launches, but that SPAC is currently trading at $82.10 (800% increase from the day it went public, AND at that level without even declaring a specific target!).
If you are going to invest, you should at a minimum have fun doing it.
It is not meant to be insulting, or demanding, or what ever.
The true purpose of this board is to share due diligence and brainstorm on this particular investment.
Complaining that the company isn't being transparent enough for you doesn't help any of us. These are just wasted posts. The CEO of AXIM is not going to hold your hand and reassure you that your investment is secure. That is not his job, nor what a true investor wants him to waste his precious time doing. Inherent in all investments is risk, and if you are not comfortable with the level of risk that you find yourself in, then the best thing to do is to sell and move on. There are plenty of investments out there that offer much less risk (such as Apple), with, of course, much less (but still worthwhile) potential for reward.
I would much rather that John H spend his (OUR!) precious time finding an alternative manufacturing partner than Empowered, since, right now, Empowered has a bit of 'splaining to do to the FDA.
That doesn't mean that Empowered won't be helpful in the future for the mass production of Immunopass, but rather that Empowered is a bit "pre-occupied" with a small screw-up that will most likely delay its usefulness for Immunopass at this time.
As I have said, though, Immunopass' merits stand on their own, and Immunopass' importance to society at this time should be taken seriously by the Government agency responsible for authorizing its emergency use (ie: the FDA).
Give CREDIT to Johnny H for this one: Have you noticed that he hasn't put all his eggs in one basket?
We still have the DED line of products as a back-up, AND, perhaps more importantly at present, he didn't assign Empowered to be the Manufacturing Partner for those test kits!
That's all part of NOT putting your eggs all in one basket.
The guy sure seems to know what he is doing. THAT is why I am here as an investor.
I like the way he does things, because if I were in his shoes, I only wish/hope that I would have the foresight to do things so well.
Godspeed to All.
You can lead a person with logic, but you can't make them think...........
You are simplifying this way too much.
The CEO of THE company in question would never go on Ihub and create an account to address what truly is just a handful of shareholders.
Our trades, even combined, have absolutely no lasting effect on the value of AXIM.
Besides, why would the CEO risk a direct, written link to the release of "insider information" when that CEO is truly sitting on a potential multi-million (billion?) dollar windfall for the company?
It just isn't going to happen under any circumstance what-so-ever.
May I suggest that you step back a moment, rethink reality, and don't allow emotions to displace logic.
I have no idea who this new poster is, and there is only a very brief history of under 15 posts (the alias was "born" 1/18/22, and the majority of posts which have occurred were all on other boards).
However, I do like the level of intuitive knowledge this new poster brings to OTC stocks in general.
I might think I understand the science behind it all (after all, I did stay at a Holiday Inn Express last night), but this new alias adds tremendously to the financial wisdom associated with logical trading.
Worth considering whatever 2 cents this new member has to offer (and no, I am not, nor do I know who this new alias is, lol, so don't even think to go there)
Quick story for entertainment purposes....
In the 90s I had a company that provided on-site payroll check cashing services to industries throughout New York (Bell Atlantic, ConEdison, JFK and LaGuardia Airports, Lumex, Napco, Indian Point Nuclear Power Plant, etc.).
Every Thursday we sent a truck to the airport that left my facility at 3:30 am. Once safely inside the facility, Mid Island Check Cashing Corp.'s legally armed and permitted to be there (imagine inside the airport and just feet from the tarmac!) personnel cashed checks inside the cafeteria. Month after month, year after year.
One day, one of the retired NYPD Detectives that worked with me, returned with an interesting story: Apparently, the dirty old, solid metal bar that for many years was on the floor, holding the door open to the cafeteria, was in fact, a solid bar of gold that had fallen off a pallet decades earlier.
Imagine how many people walked past that bar each day, and because they didn't comprehend what that bar truly was, they had no idea of its unprecedented value.
Immunopass in 2022 (and beyond) IS that solid metal bar holding the cafeteria door open.
It is just a matter of time before someone discovers (ie: The FDA issues an EUA) just how valuable that bar truly is.
And that day will (soon) arrive...........
Rapid fire, 3 posts, all SPOT ON, and this is the first time you decide to jump in here?
Lol, I couldn't have said it better (believe me, I've tried).
I'm going to add here an "insider fact" on Mother Nature, that goes completely against Immunopass, but which makes absolutely no difference at all, because JOE PUBLIC can't go deeper than what the general media feeds them (think grain being fed to sheep).
MOTHER NATURE IS EXTREMELY EFFICIENT. To that end, MN will not make an antibody, or a protein, or an enzyme, or anything that it doesn't need at the moment. For instance, if you stop drinking milk, MN will stop producing lactase, the enzyme that digests the lactose in milk, and the next time you have ice cream, you are going to know it. BUT, for most of us, begin eating ice cream regularly, and MN will make the enzyme (lactase) once again and you will soon be fine (MN stores the information on how to make lactase, rather than waste energy making lactase when lactose isn't present).
Same thing with Montezuma's revenge. First trip to Mexico, drink the water, BAM you get sick. But stick around for a while and your body adjusts. Then when you leave and come back a year and a half later, BAM, you get sick again, but this time you adjust to the water much quicker (because your body "remembers" how to make the antibodies to fight the bacteria that causes the discomfort).
Here's the first part of my point: YOU DON'T NEED A LEVEL OF ANTIBODIES AGAINST COVID FLOATING AROUND IN YOUR BLOODSTREAM AT ALL TIMES. You just need the M cells (ie: Memory Cells - those cells which "know" how to "make" the antibodies to COVID) to be present, so that upon the next exposure, you can quickly adjust (and M Cells last a lifetime).
But JOE PUBLIC has lived in the panic of this "pandema" for so long, that the next. logical phase of this virus is the belief that a constant minimal level of antibodies will be necessary AT ALL TIMES in order to be protected against COVID - and this misguided belief will give Immunopass a lifespan way longer than it really should have.
FURTHER, the misguided belief that a minimal level of antibodies to COVID must constantly be present in the bloodstream fits Big Pharma's agenda! Using Immunopass (at home), when the level of antibodies is determined to drop below a certain level, JOE PUBLIC is going to "believe" it is time for a booster, and BP is going to sell another unnecessary dose of its vaccine.
Look, I don't condone "scamming" JOE PUBLIC, but if you can't get them to "see the light", then you might as well provide them with a product that helps them get on with their lives in a much more less stressful manner.
So, get prepared to provide JOE PUBLIC with a product that will help put them at ease, and FEED THE SHEEP WHAT THE SHEEP WANT TO EAT.....
.....and make a fortune doing so......
Now, go enjoy that completely unnecessary $2 bottle of water (today's tap water that costs less than a penny a gallon is just as good) and get on with your day.......
I thought AXIM bought Sapphire, and that Sapphire and all of their personnel now are merged into AXIM.
If that is the case, can we still speak about Sapphire as if it is a separate entity?
The more I think on it, the more I am convinced that the Rights (NVACR) are the best way to go.
You can own 1 share of stock today @ $9.75 (Total cost for a share at desired selling time will have been = $9.75)
You can own the right to buy 1 share (@ $11.50) in the future for about $0.20 (Total cost for a share at desired selling time will have been = $11.70)
OR, you can buy the Rights to 1 future share for $2.00 (you would need to purchase 10 NVACR today at a cost of $0.20 each). (Total cost for a share at desired selling time will have been = $2.00)
If I am reading this correctly, those Rights go into effect "after a merger has commenced", which means upon the announcement of a merger target (or very soon thereafter).
Since it has always been my intention to wait until after a merger has been announced in order to sell any interests in NorthView Acquisition Corp., then owning shares or owning Rights to shares makes no difference.
In effect, the Rights give you the ability to own almost 5 times as many (whole) shares (4.875 times), which turns your investment into an automatic 487.5% gain upon the Announcement of the Acquisition Target (AOTAT) even if the current sales price for NVAC remains the same after the announcement!
If post AOTAT the price drops substantially, it would have to drop by almost 80% for you to experience a loss.
If post AOTAT the price rises, your gain could well be above 500%
Based on the above, I have a NVAC sale price target of $14.25. This would be a % increase above today's value ($9.75) of + 46%, with an effective % Rate of Return of more like over 600%.
Damn, I hope my calculations and my thinking are correct.
Godspeed.
My feeling is that the product has not changed.
Immunopass is as important to society today as it was prior to the black eye that the FDA put on Empowered.
IF there was a legitimate EMERGENCY USE for Immunopass before (which I believe there was), that EMERGENCY USE hasn't changed because Empowered sold 2,100 test kits without the FDA's prior approval to do so.
IF there is a public need for Immunopass (which, again, I believe there is), then the FDA is not going to "cut off it's own nose to spite its own face."
Sanction Empowered in any way you want, but don't make the public suffer because of Empowered's stupidity.
I believe, whatever delays the FDA's Class I Recall will have on the final approval of Immunopass for an EUA, those delays will be (very) short lived.
Interesting article, thanks for the update.
As I do watch the outstanding shares very closely, I still see the float at 136,178,000 and it has been there for some time now.
I guess that number will change with the 10-Q due May 15th, that is, if the company is actually selling shares in order to pay bills.
My thoughts are that the stock (NVAC) and the rights (NVACR) will add value if the stock price rises, but it is the options/warrants (NVACW) that promise to deliver the greatest % return when the time comes (ie: announcement of acquisition - AOA).
Since the intent is to sell all 3 (NVAC, NVACR, NVACW) upon AOA, then wouldn't it make sense to sell NVAC now in exchange for NVACW?
(With the basic assumption that an AOA will occur, which is the sole purpose of the SPAC to begin with).
For that matter, upon AOA, since NVACR is 1/10th of NVAC, wouldn't it be better to sell NVAC now in exchange for NVACR, since NVAC is currently $9.74 and NVACR is much less than 1/10th of that?
NVACR is currently trading at about .17, but 1/10th of what NVAC is currently trading at is .974, so if you sell NVAC and buy NVACR, you essentially are getting more than 5x as much stock upon AOA that will be trading at (1/10th of) the price of NVAC upon AOA.
In other words, if the AOA occurred tomorrow, and NVAC remained at today's value of $9.74, then NVACR would be worth 1/10th of that, or $.974 - which is 5.7 times what it is worth today!
Doesn't that turn NVACR into an immediate, guaranteed 5 bagger upon AOA?
Going to have to sleep on this, but it seems that shifting $ out of NVAC and into NVACR and NVACW might be the prudent thing to do.....PROVIDING that the SPAC does what its whole "reason for being" is to do - Take over a acquisition target.
At first (August/September/October 2021) just bought, then later bought and sold, bought and sold, bought and sold, every time winding up holding more in the trust than was there before.
I thought to stop when at 1%, but somehow over the ensuing months doubled that and then some.
I have always been a man of my word (contrary to the very one-sided story that might be out there in the media about me), but that is one of the only things that no one can take from me.
On my left forearm I have the tattoo "We The People", and on my right, "In God We Trust".
....and yes, I do put "my money" where my mouth is.
Now, I, like Dean, would thank you for your shares, Kap, but I haven't been able to free up any dry powder as of yet (though it is very much in the works and should be available by the end of this week or early the next).
Godspeed to All.
Absolutely not, and then some.
It is a long story still in the making (10+ years comes February, 2022 - which you will be able to read about in "When You're Going Through Hell"), but my decade long battle with the Federal Government has ultimately left me with nothing but my Faith and my Freedom (the latter of which could be taken come in just a few months from now). From a true Patriot (I was with the US Army from 83 to 92) once worth in the low 8 figures, I have been financially brought to the point of having auctioned off most of my personal items at the end of 2021. No car, no house, nada but that which I can actually carry on my back. Right now, everything is at the good graces of family and friends. I often joke that I haven't got a pot to piss in, but blessed to be surrounded by many who would lend me one (and certainly, if I did piss in the pot, I'm sure they would let me keep it!).
But God has always been GREAT with me, and through all this, I still feel like the luckiest person on earth. To that end, in the late 50's, my great Uncle Frank held the patent for Double Hung Windows, and if you think the market for Immunopass is practically unlimited, think of what the market size was like for that invention!
To make a long story short, his son (my mother's cousin) never married. Extremely wealthy, now in his early 90s, he recently left a sizeable trust for a few of us to share, and of the 5, I have been entrusted with the ability to use a portion of that trust to do some relatively risky trading.
So, yes, I don't personally own a single share of AXIM, but rest assured, I am "responsible" for an amount of shares that, combined, can actually be referred to as an integer percentage of the current shares outstanding.
Needless to say, I am VERY much on this rollercoaster ride, and, honestly, loving every minute of it (most of the time) - with a HUGE thanks to each and every one of you on this board, who have helped me substantially with my due diligence on this play (although, of course, not my only source, and AXIM not my only play, albeit by far the riskiest one).
So yes, I am on this rollercoaster ride with the rest of you (I got on in August of 2021 after having studied AXIM from afar for at least 6 months), and once I got on, I fully committed to staying on the ride to the end.
Three things:
Cancer was their main theme. Currently, the DED line is their near term money maker that will carry them into the future. Revenues from their cancer research are still years down the road.
This is not the "really big piece of negative news" that you may think it is. I mean, for Empowered maybe, but Immunopass is still the "First-in-Class" product hoping to help society get through this particular emergency crisis. In all truth, if AXIM put out a statement saying "this is no big deal", no one would believe it. There just isn't too much that can be said....just yet....but perhaps, if AXIM does switch manufacturers, then there will be something worth reporting.
The funding of AXIM will soon be via the DED line, if that hasn't started already. Keep in mind, Empowered is NOT the manufacturer of the DED test kits , so this recent bit of news in no way effects the DED line, and it is the revenues from the DED line that were deemed to carry AXIM forward into the future - regardless of the outcome of Immunopass.
REMEMBER from the last 10-K: The DED line revenues are believed to make AXIM profitable by the end of 2022.
There is still a hell of a lot of life left in this company.
This is just another hill in the rollercoaster ride.
Keep in mind:
I came to the same conclusion as you did.
As for suing Empowered, of course, one needs to know the intricate details of the problem and upon which parties the fault lies (eg. was there some kind of a misunderstanding between Empowered and an individual at the FDA regarding marketing of the test kits pre FDA approval?).
I know this is the most "severe" type of recall ("Class I Recall"), but truth be told, clearing out the fog, this is as simple as 2,100 test kits being sold over an 11 month period without the pre-approval of the FDA to market those test kits.
A MARKETING MISTAKE, not a defect in the product in any way!
No one was hurt, and when notified of the problem, Empowered contacted the buyers, informed them of the problem, and issued a recall.
Hard Stop.
In no way does the recall change the Emergency Use merits of the product. The test kit still has every single merit that it had going into the application for its Emergency use (mass production, inexpensive, rapid results, at home, over the counter, no prescription or medical professional intervention necessary, etc.).
So if you sue Empowered, what financial loss due you sue for? (since, in reality, it is Empowered that will be bearing the cost of any financial penalty from the FDA, not AXIM). Also, can anyone prove definitively that Empowered's error (selling 2,100 test kits without first getting the FDA's blessings to do so) actually delayed the EUA, and if so, by how long?
To your second point, switching manufacturers, that is undoubtedly being explored at this time, at least for the short term, and may have already been resolved (unbeknownst to We the Shareholders). Logic dictates that the management at AXIM is looking to distance themselves from Empowered at least until the error is completely resolved with the FDA, in order to get Immunopass out to market as soon as possible.
Keep this in mind: An EUA issued by the FDA is deemed necessary for the benefit of the public. The EUA is NOT issued for the financial benefit of the company or its shareholders.
So if Immunopass has an emergency use benefit to the public, this particular Class I Recall doesn't change that in any way! 2,100 test kits were not recalled because of some defect in the product or its test results.
Immunopass is today exactly the same test kit as it was before the recall.
If Immunopass merits obtaining an EUA because of its potential to benefit the public, then the problem with Empowered should not interfere with the issuing of that EUA.
You are not seeing that right.
The FDA isn't involved in any kind of "Fraud" what-so-ever.
The FDA is doing what they are responsible to do - report a violation when they see it (albeit, it took them over 4 weeks to do so, which in my opinion has some questionable aspects to it!).
The FDA didn't make any instructions to investors in their statement. It is up to YOU (as it always is) to analyze the information and come to your own conclusions.
Bottom line here is that the FDA had to report this, in as dry terms as possible, and in alignment with their protocols.
BUT, anyone truly looking into this can see that it is all BS.
ABSOLUTELY NOTHING has changed in regards to the merits of Immunopass, or even the test results for that matter.
Whether you sell on this news, or buy on this news (or hold on this news) is entirely your choice.
The FDA merely has a social obligation, based upon its founding principles, to put this information out there, regardless of how truly meaningless and trivial that information might be.
IF the FDA "covered this up" and didn't make a statement, perhaps then there would have been "Fraud" on their behalf.
.....but the FDA did its job! It is up to YOU the investor as to how you feel comfortable interpreting that information.
....and I, personally, believe it is a bunch of BS and a sign that the FDA is in its final stages before issuing its EUA.
You see, the FDA has to dot its "i"s and cross its "t"s just like anyone else, before it publicizes its final decision.
IMHO, this announcement was exactly that - merely a CYA and making sure to cover all bases, before the FDA wraps this one up and gives it its final stamp of approval.
......and based on my beliefs, I intend to buy some cheapies next week if the opportunity (ie: spare funds) affords it.......
If my calculations are correct, then taking into consideration any "fully convertible" units purchased (ie: there is no loss because of fractions in the total number of units purchased), if you take the final share price after a target is announced and multiply that price by 1.14, then you will have the actual value of your investment (taking into consideration all of the Rights and Warrants) - as long as the final share price is above $11.50.
In other words, if NVAC goes to $15 per share, and you have a full compliment of warrants and rights from when you purchased an even number of units, then the additional value of those warrants and shares adds another .43 to the share price:
$15 x 1.14 = $17.10
So, when the time comes, those warrants and rights will add another 14% to your gross proceeds.
Now, the higher the stock price, the greater the % return from the warrants and rights:
$11.50 = 10.00% (the warrants add no value at this price)
$15.00 = 21.67%
$20 = 31.25%
$25 = 37.00%
$30 = 40.83%
$35 = 43.57%
$40 = 45.63%
"options" can return much bigger percentage gains and rewards that just purchasing the stock outright by itself.
The "rights" clearly add 10% to the final value, but it is the Warrants that result in the additional ercentage gainds at higher stock prices.
Godspeed.
So my bottom line is this: I agree with BlueSkys. This "Class I Recall" in which "There have been no reports of adverse health consequences or death from use of these tests", and which took the FDA over a month to make public, isn't nearly as serious as the FDA wants anyone to believe.
I see this as just a "warning" to anyone else that they had better dot their "i"s and cross their "t"s before they face the same, dire, "Class I Recall" proclamation that Empowered just received.
Interesting that the FDA took over 4 weeks (37 days) to publish this most serious type of recall discovery
I guess, if you are going to "sit" on this for 37 days, then it really wasn't so bad after all?
BUT, if you are going to approve a product, and want to take advantage of the "wink-wink" that Blueskys is suggesting in his "conspiracy theory", then you had better do it before issuing a final decision on the EUA. (In other words, I see this "weak" announcement as a sign that final approval is closer than ever before).
I am SO GLAD to see that this most serious type of recall
Having had time to think on this, here are my thoughts:
I remember a few months back when Empowered and AXIM changed their websites, adding a disclaimer that their products were not yet approved by the FDA. That must have come about early during the FDA's evaluation process, so the "error" has been known about for quite some time now. Even so, the FDA has not said at any time that they were denying the EUA for Immunopass. Most importantly,
I see what you are saying, found in the section about FDA Actions:
Yes....encouraging.....but comes Monday, rest assured, we will be testing new lows.
Oh no, AXIM certainly is not dead, nor is Immunopass.
Immunopass is an excellent product.
Empowered, on the other hand, is the arsehole that marketed the product with improper advertising, all be it just 2,100 units.
AXIM and the DED Line will continue on unscathed and will be profitable by the end of 2022, and the stock (IMO) will be trading over $1 as a result.
As for Immunopass, AXIM needs to take the product and distance itself from the manufacturer (Empowered Diagnostics) and just find itself another manufacturing partner.
The FDA didn't voice a complaint about Immunopass, just Empowered Diagnostics for Empowered making a false claim in their advertising.
Immunopass, as a product itself, still holds all of the same merrits it had before.
I'd say Empowered is finished for quite some time - not AXIM, and certainly not Immunopass.
No doubt, the switch is a set back for the EUA, but Immunopass itself is still First-in-Class.
F$%king never saw THAT coming in my f$%king useless movie scenarios.............
It was in the article you referenced, as a link that leads you to the one I have posted below.
From your linked article, go all the way down and click on the "Class I Recall" link.....which will bring you to the article (at the bottom of this post) which talks about the 2,100+ Immunopass Test kits.
Mentioning AXIM is irrelevant.
It is Empowered Diagnostics that is the Manufacturing Partner.
So Empowered Diagnostics screwed up royally!
Now, the question is, for how long does the FDA stick Empowered in the dog house for something that occurred between January 1, 2021 to November 11, 2021?
Well, THAT certainly can't be any f$%king good!
How is it possible that Empowered could have screwed this up so badly?
When dealing with a Federal Regulator, you certainly want to make sure you walk a very fine line.
Of little consequence, unfortunately, is that there were only 2,100 Immunopass test kits recalled.
The obvious dawns on me today:
If an EUA is issued, we won't hear about it on the FDA website, but rather via a Press Release from AXIM.
Having waited this long, AXIM most likely has a PR already prepared and ready to go, and will issue its PR as soon as it reasonably can after hearing from the FDA, regardless of the day or time, and only delayed by the time necessary to tweak such a PR and standard business hours.
The FDA website CURRENTLY is only good for giving us an idea of what the FDA is doing and what they are focused on.
AFTER such PR, the FDA website will certainly add credence to the news, AND MORE IMPORTANTLY, alert many others who watch the website of Immunopass' approval.
....IF and when the EUA is ever issured.......
It should be interesting to see the effect of the Press Release on the pps and volume, and then a few days later to see the effect of the FDA website publication as to the same.
....IF and when the EUA is ever issured.......
Day 3 after the split:
NVACW: 504,695 shares @ $0.22
NVACR: 36,436 shares @ $0.19
NVAC: 1,575,400 shares @ $9.74
The numbers seem odd.
Should wait about a week or so to see how these numbers settle in.
Wow, yesterday - the 1st day post the unit split - was some day!
NVACW: 504,695 shares @ $0.21
NVACR: 1,590,700 shares @ $0.16
NVAC: 1,575,400 shares @ $9.70
There was a single trade of NVAC of over $4.6 million!
Total dollars worth of NVAC traded yesterday was $15 million.
And, most of the action was buys, not sales (Green trades, not red ones).
MAYBE that had something to do more with the splitting up of the units and NOT actual trades?
If that be the case, then the splitting up of the units has to certainly be complete. Everything starting this morning should all be trades.
38110
I received a PM last night that I believe is worth repeating here.
It was from someone I have never heard from before, nor has that alias posted on this board at any time.
It was in "response" to my post about the DED line revenues driving up the pps.
Here it is:
I like that thinking.
Those most likely to get hurt on a rollercoaster are the ones who get off before the ride stops.
But keep in mind, the first reporting of the DED line revenues will be in the first Quarter 10-Q, which won't come out until at least May 15, 2022, and as those revenues cover the first quarter when the DED line was effectively launched, I don't expect them to be too exciting.
It is the GROWTH in those revenues - from the first 10-Q released on May 15 to the one due out on August 15 - that could drive the pps North.
So yes, it seems like it could be a good long term strategy to keep your eye on the DED Line revenues, but it is an EUA from the FDA that is most likely to bring the pps up, and up substantially in the near future, IF antibody levels are accepted by society as a replacement for the highly inaccurate COVID Virus test kits.
Besides, whatever decision the FDA makes, THAT decision will most certainly be here before August 15, 2022.
Godspeed.
The Warrants portion of the units are now trading at FULL Warrants (each Warrant gives the holder the right to purchase an entire share at $11.50 in the future), so the number of warrants received in the split was half of the total number of units purchased.
Therefore, after Day 1 of the split, the "units" were effectively trading at $10.02, a drop of 8 cents per unit.
It appears that the following is about how the units have split up, based upon LOW BIDS:
NVAC = $9.67
NVACW = $0.22
NVACR = $0.20
....as of 1/25/2022 (1 day after split).
38110
NVAC was $9.71, NVACW closed at .22, NVACW was at .20, totaling to $10.13
Well, if it means anything at all, Siemens received follow up EUAs on their LABORATORY NEEDED antibody test kits one on the 19th, two on the 18th, and Diazyme received 2 follow up EUAs for their LABORATORY NEEDED antibody tests.
Total of 5.....all require a laboratory at some point to obtain/interpret the results.